Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Carcinoma and EPCAM[original query] |
---|
Fc?R polymorphisms and clinical outcome in colorectal cancer patients receiving passive or active antibody treatment. International journal of oncology 2010 Dec 37 (6): 1599-606. Wang Biyun, Kokhaei Parviz, Mellstedt Håkan, Liljefors Mar |
Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus. PloS one 2014 9 (4): e93416. Yu Xiaohe, Ge Naijian, Guo Xu, Shen Shuqun, Liang Jun, Huang Xiaojun, Wan Shaogui, Xing Jingliang, Huang Qichao, Yang Ye |
ß-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study. Virchows Archiv : an international journal of pathology 2015 Aug . Ando Sumiyo, Shibahara Junji, Hayashi Akimasa, Fukayama Masas |
BRAF V600E mutation in biliary proliferations associated with a -antitrypsin deficiency. Histopathology 2016 Sep . Angkathunyakul Napat, Rosini Francesca, Heaton Nigel, Foskett Pierre, Quaglia Alber |
Circulating Tumor Cells in Breast Cancer: Correlation with Clinicopathological Parameters, Hormone Profile and MicroRNA Polymorphisms. Turk patoloji dergisi 2016 32 (3): 148-57. Bansal Cherry, Pujani Mukta, Misra Sanjeev, Srivastava A N, Singh U |
Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Nov 29 (11): 1381-1389. Ring Kari L, Bruegl Amanda S, Allen Brian A, Elkin Eric P, Singh Nanda, Hartman Anne-Renee, Daniels Molly S, Broaddus Russell |
Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma. Cancer cell international 2017 17 94. Hayashi Takehiro, Yamashita Taro, Okada Hikari, Nio Kouki, Hara Yasumasa, Nomura Yoshimoto, Hayashi Tomoyuki, Asahina Yoshiro, Yoshida Mariko, Oishi Naoki, Sunagozaka Hajime, Takatori Hajime, Honda Masao, Kaneko Shuic |
MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma. Cancer research 2020 2 80 (8): 1720-1734. Gramantieri Laura, Pollutri Daniela, Gagliardi Martina, Giovannini Catia, Quarta Santina, Ferracin Manuela, Casadei-Gardini Andrea, Callegari Elisa, De Carolis Sabrina, Marinelli Sara, Benevento Francesca, Vasuri Francesco, Ravaioli Matteo, Cescon Matteo, Piscaglia Fabio, Negrini Massimo, Bolondi Luigi, Fornari Frances |
The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma. Journal of nanobiotechnology 2021 3 19 (1): 74. Yi Bin, Wu Tian, Zhu Nan, Huang Yao, Yang Xiaoyu, Yuan Lei, Wu Yingjun, Liang Xiaofei, Jiang Xiaoqi |
Integrated Multi-Omics Data Analysis Reveals Associations Between Glycosylation and Stemness in Hepatocellular Carcinoma. Frontiers in oncology 2022 7 12 913432. Liu Peiyan, Zhou Qi, Li J |
Extracolonic tumours in a pedigree with EPCAM-related Lynch Syndrome. European journal of medical genetics 2022 4 65 (5): 104479. Alves da Silva Joana, Castedo Sérgio, Pedroto Isabel, Marcos-Pinto Ricar |
rs62139665 Polymorphism in the Promoter Region of EpCAM Is Associated With Hepatitis C Virus-Related Hepatocellular Carcinoma Risk in Egyptians. Frontiers in oncology 2021 11 754104. Motawi Tarek Mohamed Kamal, Sadik Nermin Abdel Hamid, Sabry Dina, Fahim Sally Atef, Shahin Nancy Nab |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: